Leukaemia Foundation media releases. | Leukaemia Foundation - Part 3

Latest news

Generous family legacy helps fund blood cancer researchers of tomorrow

Tuesday 10 December 2019

The memory of a mother lost to blood cancer and the strength and generosity of a family left behind has led to a lasting legacy to help support the brightest young minds in blood cancer research.

The Frederiks Foundation was the legacy of Brisbane accountant Cor Frederiks

Read More

Aussies urged to answer call for greatness in blood cancer battle as Leukaemia Foundation unites with Spartan

Thursday 5 December 2019

Aussies who dare take on the world’s top obstacle race course can now rise to the challenge of supporting those facing one of the toughest battles of all, with the Leukaemia Foundation combining forces with Spartan Race to tackle blood cancer.

For the first time ever, Spartans

Read More

Leukaemia Foundation joins Giving Tuesday Australia

Monday 2 December 2019
Generous Australians are encouraged to help the Leukaemia Foundation put a present under the Christmas Tree for children living with blood cancer as part of this year’s Giving Tuesday Australia.

Blood cancers like leukaemia and lymphoma remain the most commonly diagnosed childhood cancers in Australian children

Read More

Monash University’s Dr Khai Li Chai receives scholarship to further research into immunoglobulin therapy

Wednesday 27 November 2019

The Leukaemia Foundation and the Haematology Society of Australia and New Zealand (HSANZ) have collaborated to award Monash University PhD student Dr Khai Li Chai a three-year, $120,000 scholarship.

The funding will support Dr Chai’s research into hypogammaglobulinaemia in people living with a range of blood cancers:

Read More

Burden lightened for rural patients needing life-saving treatment

Friday 22 November 2019

The Leukaemia Foundation’s patient accommodation facilities in Townsville will continue to be a home away from home for blood cancer patients from rural and remote Queensland, following a sizable donation from the Freemasons.

As Aramac Masonic Lodge, some 550km away closed its doors for the last time

Read More

Vital cancer treatment now available through Pharmaceutical Benefits Scheme (PBS) for more Australians living with blood cancer

Wednesday 20 November 2019
The Leukaemia Foundation has welcomed news that cancer treatment, blinatumumab (Blincyto®) will be available for patients in the early stage of acute lymphoblastic leukaemia (ALL) who have minimal residual disease (MRD, through the Pharmaceuticals Benefits Scheme (PBS) effective December 1, 2019. A patient has MRD

Read More

Leukaemia Foundation HSANZ PhD scholarship for Monash University researcher

Monday 18 November 2019

The Leukaemia Foundation and the Haematology Society of Australia and New Zealand (HSANZ) are proud to announce Dr Liesl Butler from Monash University has been awarded a $120,000 New Investigator PhD scholarship for 2020.

The funding will support Dr Butler’s research into developing improved biomarkers and targeted

Read More

More than 35,000 Australians will unite for zero lives lost to blood cancer by 2035

Thursday October 10 2019

On Friday 11 October more than 35,000 Australians will unite to walk together to shine a light on blood cancer at the Leukaemia Foundation’s annual Light the Night event. For the first time, this year they’ll also be walking as one towards a bold new

Read More

Australians raise the bar for the Leukaemia Foundation’s U.G.L.Y Bartender of the Year

More than 800 bartenders across the country have come together to be ‘U.G.L.Y.’ for the Leukaemia Foundation’s U.G.L.Y. Bartender of the Year awards. The extraordinary group of Aussies raised a massive $920,000 to pay for 11,500 nights of accommodation, essential for regional families affected by blood cancer who must

Read More

Leukaemia Foundation supports latest Pharmaceutical Benefits Scheme (PBS) listings for blood cancer patients

Monday September 30 2019

The Leukaemia Foundation has welcomed news Australians living with Philadelphia chromosome B-cell precursor acute lymphocytic leukaemia (B-ALL) will now have access to treatment options blinatumumab (Blincyto®) and inotuzumab ozogamicin (Besponsa®) through the Pharmaceuticals Benefits Scheme (PBS) effective October 1, 2019.

Leukaemia Foundation CEO Bill Petch joined Federal

Read More

Share this page